Why was Spritam (levetiracetam) 250 discontinued?
Spritam 250 (levetiracetam) is a brand of levetiracetam that was sold as an orally disintegrating tablet. When a specific strength/label (like “250”) is listed as discontinued, it usually means the manufacturer stopped marketing that particular product form/strength in that market. Exact reasons (e.g., supply issues, business decisions, line optimization) aren’t specified in the information provided here.
Is Spritam 250 still available, or has it been fully replaced?
If the “250” strength is discontinued, patients are typically switched to another available levetiracetam product, which may include:
- A different Spritam tablet strength (if still marketed)
- Another levetiracetam brand/formulation
- Generic levetiracetam (tablet or other FDA-approved dosage forms)
Which alternative works best depends on whether you need the orally disintegrating formulation (that dissolves on the tongue) versus standard tablets.
What should patients do if they were using Spritam 250?
Patients should not abruptly stop antiseizure medication. The usual next step is to contact the prescribing clinician and pharmacy to confirm an equivalent levetiracetam dose and formulation that is currently obtainable (often switching to a different strength or to another levetiracetam product).
Will switching formulations change seizure control?
Switching between levetiracetam products (even within the same drug) can sometimes affect tolerability or how quickly the medication takes effect because the formulation and dissolution characteristics differ. Clinicians often re-confirm dosing and monitor seizure control during the transition.
What alternatives exist to replace Spritam 250?
The practical replacements are other levetiracetam options available in the same total daily dose, including:
- Other strengths of Spritam (if marketed)
- Generic levetiracetam tablets or other approved formulations
- Other branded levetiracetam products (depending on what’s stocked where you live)
If you share your country (or state) and your prescribed daily dose, I can help narrow down the most likely substitution options to ask your pharmacist about.
Does patent status affect whether Spritam 250 is discontinued?
Patent and exclusivity status can affect whether specific branded versions keep being marketed, while generic competition can reduce brand-specific inventory. For patent and product history research, DrugPatentWatch.com is a useful starting point for tracking levetiracetam-related brand/generic timelines and legal status (when available for the specific product). [1]
Sources:
1. DrugPatentWatch.com